Eli Lilly & Co |
8.59% |
UnitedHealth Group Inc |
7.34% |
Novo Nordisk A/S |
6.46% |
AbbVie Inc |
5.20% |
Thermo Fisher Scientific Inc |
4.96% |
AstraZeneca PLC |
4.66% |
Roche Holding AG |
4.04% |
Intuitive Surgical Inc |
3.87% |
Danaher Corp |
3.86% |
Johnson & Johnson |
3.58% |
Sanofi |
3.46% |
Boston Scientific Corp |
3.42% |
Stryker Corp |
3.29% |
Zoetis Inc |
3.25% |
Vertex Pharmaceuticals Inc |
2.77% |
Merck & Co Inc |
2.46% |
Bristol-Myers Squibb Co |
2.26% |
CSL Ltd |
2.26% |
McKesson Corp |
2.01% |
Alcon Inc |
1.91% |
Cooper Cos Inc |
1.91% |
Neurocrine Biosciences Inc |
1.88% |
Zimmer Biomet Holdings Inc |
1.85% |
SPDR S&P Biotech ETF |
1.70% |
Centene Corp |
1.24% |
Lonza Group AG |
1.11% |
Humana Inc |
1.02% |
Pfizer Inc |
0.97% |
Royalty Pharma PLC |
0.91% |
Teleflex Inc |
0.89% |
ARGENX SE - ADR |
0.84% |
Amplifon SpA |
0.80% |
Sartorius AG |
0.80% |
Align Technology Inc |
0.76% |
Straumann Holding AG |
0.74% |
Neogen Corp |
0.65% |
AptarGroup Inc |
0.58% |
Agiliti Inc |
0.50% |
Asahi Intecc Co Ltd |
0.49% |
MSILF GOVERNMENT PORTFOLIO MSILF GOVERNMENT PORTFOLIO |
0.33% |
JMDC Inc |
0.22% |
CARIS LIFE SCIENCES, INC |
0.05% |